The RWE Revolution: How Canadians Can Benefit from a New Era of Health Data

Historically, health data from randomized clinical trials has been seen as the most important source of evidence to evaluate the value of innovative health technologies.

However, patients, policymakers, payers and clinicians are increasingly relying on Real-World Evidence (RWE) to reduce the uncertainty that often accompanies new therapies, treatments and diagnostics.

On June 19, 2023, the RHC hosted a conversation on why harnessing the power of RWE for Canadians is so important - and how new partnerships, programs and investments are needed to unlock this opportunity.